Guy Topping is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Non-Executive Director at Torbay Pharmaceuticals since December 2023, Topping has been pivotal in delivering niche sterile pharmaceutical products globally. As the Enabler, Director, and Consultant at AseptA Limited since August 2012, Topping has provided strategic support to venture capital, private equity, and family offices. A former Managing Director at Mi3 Limited, Topping successfully navigated the challenges posed by Brexit, Covid, and regulatory changes while enhancing service delivery. Additionally, Topping has held key leadership roles at EVA Pharma, WHEATON Industries, and Fresenius Kabi, demonstrating a strong track record in operational management and business turnaround strategies. Educational qualifications include an MBA from the University of Cape Town and a B.Pharm from the University of Port Elizabeth, complemented by advanced professional training in Non-Executive Directorship.